Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 May;37(3):264-72.
doi: 10.1007/s00059-012-3610-4.

Antithrombotic therapy in patients with acute coronary syndrome and diabetes mellitus

S Farhan  1 , I Tentzeris, M K Freynhofer, B Vogel, K Huber
Affiliations
Review

Antithrombotic therapy in patients with acute coronary syndrome and diabetes mellitus

S Farhan et al. Herz. 2012 May.

Abstract

Acute coronary syndrome (ACS) is associated with high mortality even in the acute phase as well as in the post-acute (chronic) phase. Diabetes mellitus type 2 (DM-2), on the other hand, further increases mortality after ACS. Several new antiplatelet and antithrombotic drugs available for clinical use have also been investigated in patients with DM-2, and the guidelines of the European Society of Cardiology (ESC) were recently adapted. However, in daily clinical practice choosing the most suitable regimen is a challenge in many cases. This review article aims to shed light on and simplify antiplatelet and antithrombotic therapy in ACS patients with DM-2 in order to ease the clinician's decision-making.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Thromb Haemost. 2010 Jan;103(1):213-23 - PubMed
    1. N Engl J Med. 2009 Jan 8;360(2):129-39 - PubMed
    1. Nat Rev Drug Discov. 2011 Apr;10(4):255-6 - PubMed
    1. Diabetes Care. 2003 Jan;26 Suppl 1:S87-8 - PubMed
    1. N Engl J Med. 2007 Jun 7;356(23):2388-98 - PubMed

MeSH terms

Substances

LinkOut - more resources